Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP3
|
ENSG00000172845.9 | SP3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
SP3 | chr2_174828619_174828770 | 253 | 0.959552 | 0.79 | 1.2e-02 | Click! |
SP3 | chr2_174821577_174821728 | 7295 | 0.324185 | -0.73 | 2.6e-02 | Click! |
SP3 | chr2_174830683_174830909 | 366 | 0.930092 | 0.72 | 2.9e-02 | Click! |
SP3 | chr2_174829066_174829221 | 138 | 0.979961 | 0.72 | 2.9e-02 | Click! |
SP3 | chr2_174696294_174696488 | 132556 | 0.055137 | 0.72 | 3.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_130341357_130341579 | 1.32 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
168 |
0.97 |
chr6_33589286_33590289 | 1.25 |
ITPR3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
626 |
0.65 |
chr20_62185445_62185854 | 1.23 |
C20orf195 |
chromosome 20 open reading frame 195 |
153 |
0.91 |
chr1_6674280_6674659 | 1.23 |
KLHL21 |
kelch-like family member 21 |
151 |
0.86 |
chr11_124615580_124615731 | 1.20 |
RP11-677M14.2 |
|
578 |
0.58 |
chr9_102058504_102058983 | 1.19 |
ENSG00000222337 |
. |
12439 |
0.24 |
chr6_143266416_143266570 | 1.14 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
155 |
0.97 |
chr19_11372520_11373011 | 1.14 |
DOCK6 |
dedicator of cytokinesis 6 |
363 |
0.78 |
chr17_1928692_1929031 | 1.13 |
RTN4RL1 |
reticulon 4 receptor-like 1 |
222 |
0.83 |
chr17_7308279_7308430 | 1.11 |
NLGN2 |
neuroligin 2 |
161 |
0.77 |
chr1_43814755_43814906 | 1.11 |
RP1-92O14.3 |
|
9499 |
0.1 |
chr14_23450829_23451172 | 1.11 |
AJUBA |
ajuba LIM protein |
205 |
0.66 |
chr20_57582352_57582503 | 1.09 |
CTSZ |
cathepsin Z |
125 |
0.95 |
chr14_105218972_105219273 | 1.09 |
SIVA1 |
SIVA1, apoptosis-inducing factor |
315 |
0.83 |
chr11_69457709_69458273 | 1.09 |
CCND1 |
cyclin D1 |
2017 |
0.36 |
chr2_200322083_200322803 | 1.08 |
SATB2-AS1 |
SATB2 antisense RNA 1 |
20 |
0.87 |
chr22_37956672_37957106 | 1.07 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
402 |
0.77 |
chr6_42420800_42420951 | 1.06 |
TRERF1 |
transcriptional regulating factor 1 |
1086 |
0.55 |
chr1_20125793_20126331 | 1.03 |
TMCO4 |
transmembrane and coiled-coil domains 4 |
225 |
0.92 |
chr17_7788638_7788948 | 1.02 |
LSMD1 |
LSM domain containing 1 |
266 |
0.71 |
chr19_17008131_17008363 | 1.00 |
CPAMD8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
1221 |
0.33 |
chr6_36098764_36099262 | 1.00 |
MAPK13 |
mitogen-activated protein kinase 13 |
573 |
0.74 |
chr9_35116014_35116425 | 1.00 |
FAM214B |
family with sequence similarity 214, member B |
119 |
0.94 |
chr7_107643634_107643920 | 0.99 |
LAMB1 |
laminin, beta 1 |
77 |
0.97 |
chr16_70473041_70473208 | 0.99 |
ST3GAL2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
133 |
0.94 |
chr11_115630420_115630914 | 0.97 |
ENSG00000239153 |
. |
132764 |
0.06 |
chr13_110439180_110439367 | 0.97 |
IRS2 |
insulin receptor substrate 2 |
358 |
0.92 |
chr19_31840219_31840556 | 0.96 |
TSHZ3 |
teashirt zinc finger homeobox 3 |
66 |
0.92 |
chr11_69457554_69457705 | 0.96 |
CCND1 |
cyclin D1 |
1655 |
0.41 |
chr14_105941189_105941585 | 0.96 |
CRIP2 |
cysteine-rich protein 2 |
232 |
0.86 |
chr12_58120070_58120511 | 0.96 |
AGAP2-AS1 |
AGAP2 antisense RNA 1 |
236 |
0.8 |
chr1_78148853_78149141 | 0.95 |
ZZZ3 |
zinc finger, ZZ-type containing 3 |
62 |
0.97 |
chr9_140008700_140009150 | 0.95 |
DPP7 |
dipeptidyl-peptidase 7 |
231 |
0.78 |
chr7_27170035_27170414 | 0.95 |
HOXA4 |
homeobox A4 |
128 |
0.82 |
chr4_25864719_25864897 | 0.95 |
SEL1L3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
227 |
0.95 |
chr4_184426878_184427177 | 0.94 |
ING2 |
inhibitor of growth family, member 2 |
208 |
0.91 |
chr19_39904013_39904164 | 0.93 |
PLEKHG2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
80 |
0.92 |
chr17_38599600_38599902 | 0.92 |
IGFBP4 |
insulin-like growth factor binding protein 4 |
38 |
0.97 |
chr17_55333458_55333748 | 0.92 |
MSI2 |
musashi RNA-binding protein 2 |
292 |
0.94 |
chr14_39572212_39572512 | 0.92 |
SEC23A |
Sec23 homolog A (S. cerevisiae) |
54 |
0.98 |
chr1_224621785_224622065 | 0.92 |
WDR26 |
WD repeat domain 26 |
76 |
0.98 |
chr7_6543400_6543638 | 0.92 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
19646 |
0.12 |
chr17_36714613_36715266 | 0.91 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
4721 |
0.18 |
chr7_559951_560161 | 0.90 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
123 |
0.97 |
chr5_1005116_1005466 | 0.90 |
ENSG00000221244 |
. |
989 |
0.44 |
chr11_67140664_67140882 | 0.88 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
435 |
0.64 |
chr19_9902856_9903204 | 0.88 |
ZNF846 |
zinc finger protein 846 |
743 |
0.48 |
chr2_175206758_175207367 | 0.88 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
4911 |
0.18 |
chr14_99712277_99712758 | 0.88 |
AL109767.1 |
|
16768 |
0.21 |
chr13_77460523_77460826 | 0.87 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
134 |
0.5 |
chr17_63556671_63556918 | 0.87 |
AXIN2 |
axin 2 |
119 |
0.98 |
chr9_100745668_100746275 | 0.87 |
ANP32B |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
328 |
0.85 |
chr3_28617160_28617794 | 0.87 |
LINC00693 |
long intergenic non-protein coding RNA 693 |
425 |
0.9 |
chr3_127175696_127176137 | 0.87 |
TPRA1 |
transmembrane protein, adipocyte asscociated 1 |
123364 |
0.05 |
chr11_2923469_2923919 | 0.87 |
SLC22A18 |
solute carrier family 22, member 18 |
44 |
0.94 |
chr8_125487165_125487316 | 0.87 |
RNF139 |
ring finger protein 139 |
261 |
0.9 |
chr17_37353212_37353473 | 0.87 |
CACNB1 |
calcium channel, voltage-dependent, beta 1 subunit |
613 |
0.61 |
chr4_77996688_77997050 | 0.86 |
CCNI |
cyclin I |
273 |
0.93 |
chr16_67184257_67184644 | 0.86 |
B3GNT9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
667 |
0.44 |
chr6_90062554_90063004 | 0.86 |
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
212 |
0.94 |
chr10_22610168_22610350 | 0.86 |
BMI1 |
BMI1 polycomb ring finger oncogene |
119 |
0.95 |
chr9_6008187_6008379 | 0.85 |
KIAA2026 |
KIAA2026 |
382 |
0.53 |
chr1_40157482_40157633 | 0.85 |
HPCAL4 |
hippocalcin like 4 |
196 |
0.61 |
chr14_105332332_105332761 | 0.85 |
CEP170B |
centrosomal protein 170B |
892 |
0.57 |
chr3_184080089_184080493 | 0.85 |
POLR2H |
polymerase (RNA) II (DNA directed) polypeptide H |
112 |
0.89 |
chr5_175793030_175793335 | 0.84 |
ARL10 |
ADP-ribosylation factor-like 10 |
711 |
0.45 |
chr9_132427651_132428123 | 0.84 |
PRRX2 |
paired related homeobox 2 |
33 |
0.97 |
chr8_30241996_30242439 | 0.84 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
39 |
0.68 |
chr12_76424698_76425269 | 0.83 |
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
401 |
0.66 |
chr19_10341979_10342223 | 0.83 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
139 |
0.49 |
chr19_18058936_18059258 | 0.83 |
KCNN1 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
3005 |
0.18 |
chr19_18747210_18747627 | 0.83 |
KLHL26 |
kelch-like family member 26 |
357 |
0.77 |
chr8_28259515_28259714 | 0.83 |
ZNF395 |
zinc finger protein 395 |
604 |
0.66 |
chr1_27357912_27358708 | 0.82 |
FAM46B |
family with sequence similarity 46, member B |
18983 |
0.16 |
chr11_554769_555059 | 0.82 |
RP11-496I9.1 |
|
2681 |
0.11 |
chr22_26823969_26824219 | 0.82 |
ASPHD2 |
aspartate beta-hydroxylase domain containing 2 |
1145 |
0.46 |
chr12_122241648_122241827 | 0.81 |
SETD1B |
SET domain containing 1B |
349 |
0.75 |
chr7_150076358_150076609 | 0.81 |
ZNF775 |
zinc finger protein 775 |
59 |
0.95 |
chr20_34742202_34742447 | 0.81 |
EPB41L1 |
erythrocyte membrane protein band 4.1-like 1 |
340 |
0.81 |
chr15_72766829_72767031 | 0.81 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
56 |
0.98 |
chr5_110559928_110560116 | 0.81 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
238 |
0.95 |
chr4_1107333_1107580 | 0.81 |
RP11-20I20.2 |
|
29 |
0.58 |
chr3_25705652_25705988 | 0.81 |
TOP2B |
topoisomerase (DNA) II beta 180kDa |
32 |
0.93 |
chr8_19171184_19171452 | 0.80 |
SH2D4A |
SH2 domain containing 4A |
111 |
0.98 |
chr4_7940690_7941146 | 0.80 |
AC097381.1 |
|
190 |
0.86 |
chr5_170877536_170878064 | 0.80 |
FGF18 |
fibroblast growth factor 18 |
31140 |
0.17 |
chr16_11680919_11681311 | 0.80 |
LITAF |
lipopolysaccharide-induced TNF factor |
12 |
0.98 |
chr16_2582259_2582985 | 0.79 |
ENSG00000266232 |
. |
616 |
0.38 |
chr1_44399484_44399885 | 0.79 |
ARTN |
artemin |
166 |
0.92 |
chrX_147581871_147582126 | 0.79 |
AC002368.4 |
|
137 |
0.5 |
chr2_159313885_159314371 | 0.79 |
PKP4 |
plakophilin 4 |
504 |
0.62 |
chr22_44727837_44727988 | 0.79 |
KIAA1644 |
KIAA1644 |
19181 |
0.22 |
chr5_180076100_180076485 | 0.79 |
FLT4 |
fms-related tyrosine kinase 4 |
308 |
0.9 |
chr16_81349076_81349337 | 0.79 |
GAN |
gigaxonin |
649 |
0.67 |
chr10_118500836_118501537 | 0.78 |
HSPA12A |
heat shock 70kDa protein 12A |
899 |
0.64 |
chr14_99740559_99741090 | 0.78 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
2963 |
0.29 |
chr14_24868095_24868308 | 0.78 |
NYNRIN |
NYN domain and retroviral integrase containing |
209 |
0.87 |
chr17_27894284_27894699 | 0.78 |
TP53I13 |
tumor protein p53 inducible protein 13 |
293 |
0.48 |
chr2_241374262_241374834 | 0.78 |
GPC1 |
glypican 1 |
540 |
0.75 |
chr19_13260725_13261066 | 0.78 |
STX10 |
syntaxin 10 |
97 |
0.77 |
chr2_175201680_175202081 | 0.78 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
271 |
0.89 |
chr9_132244274_132244823 | 0.78 |
ENSG00000264298 |
. |
3713 |
0.27 |
chr8_61429545_61429985 | 0.78 |
RAB2A |
RAB2A, member RAS oncogene family |
25 |
0.98 |
chr1_45083265_45083554 | 0.77 |
RNF220 |
ring finger protein 220 |
8589 |
0.17 |
chr19_46272021_46272172 | 0.77 |
SIX5 |
SIX homeobox 5 |
17 |
0.84 |
chr12_50451575_50451993 | 0.77 |
ASIC1 |
acid-sensing (proton-gated) ion channel 1 |
297 |
0.85 |
chr8_145448474_145448628 | 0.77 |
ENSG00000264987 |
. |
7548 |
0.11 |
chr4_102267542_102267693 | 0.77 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
336 |
0.83 |
chr12_2904145_2904429 | 0.77 |
FKBP4 |
FK506 binding protein 4, 59kDa |
168 |
0.92 |
chr10_72647800_72648241 | 0.76 |
PCBD1 |
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha |
521 |
0.8 |
chr21_40685017_40685283 | 0.76 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
346 |
0.75 |
chr19_1490936_1491166 | 0.76 |
REEP6 |
receptor accessory protein 6 |
114 |
0.84 |
chr17_76355955_76356106 | 0.76 |
SOCS3 |
suppressor of cytokine signaling 3 |
125 |
0.95 |
chr7_116502642_116502981 | 0.76 |
CAPZA2 |
capping protein (actin filament) muscle Z-line, alpha 2 |
157 |
0.96 |
chr11_19262741_19262892 | 0.76 |
E2F8 |
E2F transcription factor 8 |
318 |
0.9 |
chr1_63788500_63788912 | 0.75 |
FOXD3 |
forkhead box D3 |
24 |
0.91 |
chr1_9895701_9896156 | 0.75 |
CLSTN1 |
calsyntenin 1 |
11344 |
0.16 |
chr1_46955506_46955688 | 0.75 |
DMBX1 |
diencephalon/mesencephalon homeobox 1 |
17071 |
0.16 |
chr8_124553811_124554260 | 0.75 |
FBXO32 |
F-box protein 32 |
589 |
0.77 |
chr3_110790117_110790473 | 0.75 |
PVRL3-AS1 |
PVRL3 antisense RNA 1 |
76 |
0.78 |
chr1_154981282_154981433 | 0.75 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5567 |
0.08 |
chr10_73532392_73533248 | 0.75 |
C10orf54 |
chromosome 10 open reading frame 54 |
435 |
0.83 |
chr15_68176890_68177288 | 0.75 |
ENSG00000206625 |
. |
44706 |
0.17 |
chr10_99094830_99094981 | 0.75 |
FRAT2 |
frequently rearranged in advanced T-cell lymphomas 2 |
447 |
0.51 |
chr19_5293472_5293908 | 0.75 |
PTPRS |
protein tyrosine phosphatase, receptor type, S |
427 |
0.88 |
chr9_137533577_137533991 | 0.75 |
COL5A1 |
collagen, type V, alpha 1 |
164 |
0.96 |
chr19_49946326_49946768 | 0.74 |
SLC17A7 |
solute carrier family 17 (vesicular glutamate transporter), member 7 |
930 |
0.27 |
chr2_241374046_241374232 | 0.74 |
GPC1 |
glypican 1 |
949 |
0.53 |
chr15_102041961_102042201 | 0.74 |
PCSK6 |
proprotein convertase subtilisin/kexin type 6 |
11894 |
0.25 |
chr3_13036200_13036525 | 0.74 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
7826 |
0.28 |
chr6_36164778_36164969 | 0.74 |
RP1-179N16.6 |
|
107 |
0.53 |
chr18_21594079_21594473 | 0.74 |
TTC39C |
tetratricopeptide repeat domain 39C |
108 |
0.94 |
chr18_77153881_77154299 | 0.73 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
1766 |
0.42 |
chr15_41199252_41199466 | 0.73 |
VPS18 |
vacuolar protein sorting 18 homolog (S. cerevisiae) |
12694 |
0.11 |
chr12_54367495_54368083 | 0.73 |
HOXC11 |
homeobox C11 |
877 |
0.24 |
chr19_11373267_11373547 | 0.73 |
DOCK6 |
dedicator of cytokinesis 6 |
279 |
0.84 |
chr17_80274181_80274428 | 0.73 |
CD7 |
CD7 molecule |
1124 |
0.35 |
chr3_150126449_150126853 | 0.73 |
TSC22D2 |
TSC22 domain family, member 2 |
529 |
0.86 |
chr15_45315162_45315313 | 0.73 |
SORD |
sorbitol dehydrogenase |
65 |
0.95 |
chr11_66234310_66234462 | 0.73 |
PELI3 |
pellino E3 ubiquitin protein ligase family member 3 |
9 |
0.95 |
chr9_139685367_139685521 | 0.73 |
TMEM141 |
transmembrane protein 141 |
363 |
0.42 |
chr12_54368526_54368847 | 0.73 |
HOTAIR |
HOX transcript antisense RNA |
45 |
0.91 |
chr5_176057523_176057674 | 0.73 |
SNCB |
synuclein, beta |
68 |
0.51 |
chr10_75633716_75633937 | 0.73 |
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma |
393 |
0.78 |
chr17_1928465_1928680 | 0.73 |
RTN4RL1 |
reticulon 4 receptor-like 1 |
67 |
0.93 |
chr3_52001896_52002228 | 0.73 |
PCBP4 |
poly(rC) binding protein 4 |
138 |
0.89 |
chr12_3186633_3186876 | 0.73 |
TSPAN9 |
tetraspanin 9 |
211 |
0.95 |
chr11_109964090_109964241 | 0.73 |
ZC3H12C |
zinc finger CCCH-type containing 12C |
78 |
0.99 |
chr3_23847762_23848140 | 0.72 |
UBE2E1-AS1 |
UBE2E1 antisense RNA 1 |
445 |
0.5 |
chr12_54412029_54412388 | 0.72 |
HOXC4 |
homeobox C4 |
1493 |
0.16 |
chr3_110790489_110790652 | 0.72 |
PVRL3 |
poliovirus receptor-related 3 |
20 |
0.69 |
chr15_72767035_72767193 | 0.72 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
128 |
0.97 |
chr3_133748771_133749015 | 0.72 |
SLCO2A1 |
solute carrier organic anion transporter family, member 2A1 |
27 |
0.99 |
chr19_11529228_11529542 | 0.72 |
RGL3 |
ral guanine nucleotide dissociation stimulator-like 3 |
136 |
0.9 |
chr5_34929563_34929714 | 0.72 |
DNAJC21 |
DnaJ (Hsp40) homolog, subfamily C, member 21 |
60 |
0.97 |
chr6_27218801_27219293 | 0.72 |
PRSS16 |
protease, serine, 16 (thymus) |
2332 |
0.31 |
chrX_25020829_25021251 | 0.72 |
ARX |
aristaless related homeobox |
13025 |
0.26 |
chr12_124873885_124874250 | 0.72 |
NCOR2 |
nuclear receptor corepressor 2 |
697 |
0.79 |
chr19_42784634_42784952 | 0.72 |
CIC |
capicua transcriptional repressor |
3379 |
0.11 |
chr8_38034540_38035180 | 0.72 |
LSM1 |
LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
626 |
0.41 |
chr11_79150433_79150655 | 0.71 |
TENM4 |
teneurin transmembrane protein 4 |
1151 |
0.54 |
chr2_24713646_24713947 | 0.71 |
NCOA1 |
nuclear receptor coactivator 1 |
1005 |
0.64 |
chr14_105767785_105767936 | 0.71 |
BRF1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
245 |
0.85 |
chr12_77719208_77719557 | 0.71 |
ENSG00000238769 |
. |
162577 |
0.04 |
chr12_54402958_54403134 | 0.71 |
HOXC8 |
homeobox C8 |
214 |
0.8 |
chr2_220307176_220307741 | 0.71 |
SPEG |
SPEG complex locus |
685 |
0.52 |
chr3_194354154_194354713 | 0.71 |
TMEM44 |
transmembrane protein 44 |
15 |
0.93 |
chr19_3097315_3097524 | 0.71 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
3011 |
0.15 |
chr3_157823617_157823969 | 0.71 |
SHOX2 |
short stature homeobox 2 |
46 |
0.64 |
chr19_11466077_11466307 | 0.71 |
DKFZP761J1410 |
Lipid phosphate phosphatase-related protein type 2 |
18 |
0.94 |
chr2_169103922_169104210 | 0.71 |
STK39 |
serine threonine kinase 39 |
585 |
0.85 |
chr9_126692210_126692405 | 0.71 |
DENND1A |
DENN/MADD domain containing 1A |
79 |
0.98 |
chr8_133787726_133787926 | 0.70 |
PHF20L1 |
PHD finger protein 20-like 1 |
0 |
0.98 |
chr3_150126096_150126425 | 0.70 |
TSC22D2 |
TSC22 domain family, member 2 |
138 |
0.98 |
chr19_45931964_45932396 | 0.70 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
288 |
0.84 |
chr17_1618775_1619150 | 0.70 |
WDR81 |
WD repeat domain 81 |
855 |
0.38 |
chr19_4064959_4065214 | 0.70 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
644 |
0.56 |
chr21_38339198_38339574 | 0.70 |
HLCS |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
447 |
0.81 |
chr4_99579955_99580652 | 0.70 |
RP11-1299A16.3 |
|
248 |
0.75 |
chr3_100428258_100428653 | 0.70 |
TFG |
TRK-fused gene |
2 |
0.98 |
chr6_44205055_44205796 | 0.70 |
HSP90AB1 |
heat shock protein 90kDa alpha (cytosolic), class B member 1 |
9399 |
0.11 |
chr19_33668057_33668280 | 0.70 |
ENSG00000264355 |
. |
190 |
0.63 |
chr4_141072409_141072710 | 0.70 |
MAML3 |
mastermind-like 3 (Drosophila) |
1564 |
0.45 |
chr6_119399577_119399871 | 0.70 |
FAM184A |
family with sequence similarity 184, member A |
184 |
0.95 |
chr18_14431127_14431407 | 0.70 |
ENSG00000200132 |
. |
100514 |
0.07 |
chr12_108523289_108523785 | 0.70 |
WSCD2 |
WSC domain containing 2 |
26 |
0.99 |
chr16_3766918_3767450 | 0.70 |
TRAP1 |
TNF receptor-associated protein 1 |
330 |
0.88 |
chr20_45035242_45035393 | 0.69 |
ELMO2 |
engulfment and cell motility 2 |
46 |
0.98 |
chr17_61699712_61699888 | 0.69 |
MAP3K3 |
mitogen-activated protein kinase kinase kinase 3 |
0 |
0.97 |
chr11_134123774_134123925 | 0.69 |
ACAD8 |
acyl-CoA dehydrogenase family, member 8 |
394 |
0.59 |
chr14_71787375_71787676 | 0.69 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
583 |
0.62 |
chr19_54982330_54982580 | 0.69 |
CDC42EP5 |
CDC42 effector protein (Rho GTPase binding) 5 |
1956 |
0.17 |
chr10_88728248_88728709 | 0.69 |
ADIRF |
adipogenesis regulatory factor |
289 |
0.5 |
chr8_21906880_21907031 | 0.69 |
DMTN |
dematin actin binding protein |
295 |
0.84 |
chr11_469322_469620 | 0.69 |
RP13-317D12.3 |
|
5572 |
0.1 |
chr6_3751810_3752094 | 0.69 |
PXDC1 |
PX domain containing 1 |
308 |
0.72 |
chr7_856467_856791 | 0.69 |
SUN1 |
Sad1 and UNC84 domain containing 1 |
126 |
0.96 |
chr11_66445050_66445277 | 0.69 |
RBM4B |
RNA binding motif protein 4B |
56 |
0.95 |
chr11_12696098_12696447 | 0.69 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
108 |
0.98 |
chr17_74378766_74379643 | 0.69 |
SPHK1 |
sphingosine kinase 1 |
796 |
0.43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.2 | 1.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.9 | 0.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.9 | 2.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.8 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.8 | 2.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.8 | 1.6 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.7 | 2.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 2.2 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.7 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.7 | 2.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.7 | 5.9 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.6 | 1.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.9 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.6 | 1.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 1.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 1.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 3.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.6 | 0.6 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 2.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 2.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.5 | 1.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 1.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 5.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.0 | GO:0001743 | optic placode formation(GO:0001743) |
0.5 | 1.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 2.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 0.5 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.5 | 2.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.5 | 1.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 0.5 | GO:1902692 | positive regulation of neuroblast proliferation(GO:0002052) regulation of neuroblast proliferation(GO:1902692) |
0.5 | 1.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.5 | 1.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.5 | 1.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 0.5 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.4 | 0.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 1.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.4 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 0.4 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.4 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.4 | 1.7 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.4 | 1.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 1.7 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.4 | 2.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 0.4 | GO:0030540 | female genitalia development(GO:0030540) |
0.4 | 2.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 0.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.4 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.4 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 1.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.4 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.4 | GO:0032682 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 1.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.4 | 1.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.4 | 1.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 3.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.4 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 1.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.4 | 0.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.4 | 1.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 0.4 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.4 | 1.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.4 | 2.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 0.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.4 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.2 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.4 | 1.6 | GO:0015853 | adenine transport(GO:0015853) |
0.4 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.4 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.4 | 1.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 2.3 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.4 | 4.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 1.1 | GO:0032801 | receptor catabolic process(GO:0032801) low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.4 | 0.4 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.4 | 1.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.4 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 1.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 0.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 0.7 | GO:0060426 | lung vasculature development(GO:0060426) |
0.4 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 3.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.3 | 0.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.3 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 1.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 2.4 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.3 | 1.3 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 1.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 2.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 1.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 2.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.3 | 1.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 1.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 1.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 1.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.9 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.3 | 0.6 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.3 | 0.6 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.3 | 1.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 2.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.9 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.3 | 0.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 0.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 3.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.9 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.3 | 0.3 | GO:0035384 | acetyl-CoA biosynthetic process(GO:0006085) thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 1.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 0.3 | GO:0007431 | salivary gland development(GO:0007431) |
0.3 | 1.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 0.3 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.3 | 1.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 0.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 1.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 2.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 1.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.3 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.9 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.3 | 0.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.3 | 0.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.8 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.3 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 0.6 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 2.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 1.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 2.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 1.6 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 1.6 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.3 | 2.7 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 0.8 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 1.9 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.3 | 0.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 0.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 1.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 2.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.3 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.3 | 0.8 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 2.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.3 | 1.9 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.3 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.3 | 1.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 2.1 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.8 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.3 | 0.8 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 1.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 1.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 1.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 0.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.3 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.3 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.2 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.2 | 0.5 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 1.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.7 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 1.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 1.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.7 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.2 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 1.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 2.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 0.2 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.2 | 1.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 3.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 2.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 1.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 0.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.2 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.7 | GO:0007140 | male meiosis(GO:0007140) |
0.2 | 0.2 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.7 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 2.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.9 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.2 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 1.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.6 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 0.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.9 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.2 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.6 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
0.2 | 2.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 1.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.8 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 3.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.8 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 1.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 1.7 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.2 | 0.6 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.2 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.2 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.6 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 1.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 3.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 1.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 2.2 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.6 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.2 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 3.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 1.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.2 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 1.4 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.2 | 1.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.6 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 2.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 1.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.8 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.2 | 0.6 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 0.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 3.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.2 | GO:0039694 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 1.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 4.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.2 | GO:0003300 | cardiac muscle hypertrophy(GO:0003300) striated muscle hypertrophy(GO:0014897) |
0.2 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.8 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 1.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.9 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.2 | GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) |
0.2 | 2.9 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.4 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 1.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.9 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 5.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.5 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.2 | 0.9 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 3.6 | GO:0006909 | phagocytosis(GO:0006909) |
0.2 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.2 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.5 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.3 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 1.5 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.8 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 2.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.2 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 2.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 4.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.2 | 1.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 1.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 | 0.5 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.6 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.2 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.2 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.2 | 0.8 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 1.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.2 | 0.5 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 0.5 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.2 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 4.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.2 | 0.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.6 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.2 | 1.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.2 | 0.3 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.6 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.2 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.1 | 1.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.6 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 1.3 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 3.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 4.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 1.5 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 2.1 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 4.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 1.4 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 1.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 2.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.9 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 11.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 3.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.4 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 1.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 1.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 2.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.3 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.4 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 2.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.4 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.4 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 4.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 2.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.6 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 1.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 3.1 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 0.4 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.1 | 2.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.7 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.4 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.1 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.7 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.7 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.1 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.6 | GO:0032606 | type I interferon production(GO:0032606) |
0.1 | 1.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.1 | 0.1 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.4 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 3.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.8 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 1.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.3 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 2.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.9 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.4 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 1.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 3.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.1 | 0.3 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.6 | GO:0070509 | calcium ion import(GO:0070509) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 1.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 1.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.9 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 4.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.8 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 1.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 8.9 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.3 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 0.1 | GO:0010559 | regulation of glycoprotein biosynthetic process(GO:0010559) |
0.1 | 4.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.0 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 1.1 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.1 | 0.2 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 1.9 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.6 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 3.9 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.1 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 1.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 3.5 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 1.3 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 3.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0072089 | stem cell proliferation(GO:0072089) |
0.1 | 1.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.4 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.5 | GO:0034508 | DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) centromere complex assembly(GO:0034508) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 1.3 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 2.4 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 1.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0010921 | regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 2.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.8 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 1.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 2.1 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 2.0 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.4 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.3 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.1 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0070972 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.2 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 7.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.6 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.4 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:1903008 | organelle disassembly(GO:1903008) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.1 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 4.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 3.0 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.7 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.1 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 5.8 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 3.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 1.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.3 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 2.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.7 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.1 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.3 | GO:0072395 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 5.1 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) modification-dependent macromolecule catabolic process(GO:0043632) |
0.1 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.4 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 3.9 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.1 | 0.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.1 | GO:0003417 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.1 | 7.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 2.9 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.8 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.2 | GO:0052646 | glycerol-3-phosphate metabolic process(GO:0006072) alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.6 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.9 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.0 | 0.1 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.9 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.0 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.0 | 0.1 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0002712 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 1.6 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 3.3 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.2 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 3.4 | GO:0016032 | viral process(GO:0016032) |
0.0 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.2 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.0 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 1.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.3 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.0 | 0.5 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.5 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.0 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.6 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.3 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.0 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0051153 | regulation of myotube differentiation(GO:0010830) regulation of striated muscle cell differentiation(GO:0051153) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.1 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 1.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.9 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.6 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.1 | GO:0014706 | striated muscle tissue development(GO:0014706) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 2.2 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.2 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.5 | GO:0046939 | nucleotide phosphorylation(GO:0046939) |
0.0 | 0.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.0 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 25.9 | GO:1903506 | regulation of transcription, DNA-templated(GO:0006355) regulation of nucleic acid-templated transcription(GO:1903506) |
0.0 | 0.1 | GO:0032655 | regulation of interleukin-12 production(GO:0032655) |
0.0 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 1.2 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 0.2 | GO:0001822 | kidney development(GO:0001822) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.2 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.0 | 0.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0009411 | response to UV(GO:0009411) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 1.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 2.2 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.4 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.0 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0001708 | cell fate specification(GO:0001708) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.3 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.2 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 2.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 1.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 2.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 2.6 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 2.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.5 | 1.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 1.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.4 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 1.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 1.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 0.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 0.4 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 3.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.7 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.4 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 1.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 5.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.3 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 2.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 2.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 6.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 6.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.1 | GO:0032059 | bleb(GO:0032059) |
0.3 | 1.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 1.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 3.0 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.3 | 1.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.3 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 2.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.8 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.8 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 8.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 2.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 3.4 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 18.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 2.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 5.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 8.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 3.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 6.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.7 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.2 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.9 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 2.8 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 9.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.9 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.6 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 2.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 4.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 5.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.8 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 2.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 3.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 6.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 1.8 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 3.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 10.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 1.1 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.1 | 4.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.3 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 10.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 8.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 12.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 6.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 4.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 7.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 9.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 2.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 2.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 3.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0032838 | cell projection cytoplasm(GO:0032838) dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 4.2 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 6.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 6.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 16.5 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 14.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.1 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 247.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.8 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 3.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 33.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.9 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 3.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.4 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 2.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 1.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 23.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.7 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 9.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.3 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.5 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.8 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 2.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 1.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 2.0 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 1.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 2.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 2.6 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 2.1 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 2.4 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 5.9 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.4 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 3.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 3.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 1.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 1.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 1.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 1.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.3 | 1.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 2.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 3.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 2.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 0.9 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 1.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 2.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 2.3 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 3.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.8 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.3 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 0.8 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.3 | 2.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 0.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.3 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.3 | 0.8 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.3 | 4.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.7 | GO:0046980 | tapasin binding(GO:0046980) |
0.2 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 1.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 5.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 2.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 0.5 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 4.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 0.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 0.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 2.4 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 0.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.7 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.2 | 1.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 8.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 2.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.6 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 0.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 1.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 1.3 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 0.4 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 2.7 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.2 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.6 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 3.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.0 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 5.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 3.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.2 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 2.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.7 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.9 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 1.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 2.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 1.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 1.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 2.9 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 0.5 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.2 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.2 | 3.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 1.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.2 | 2.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 2.1 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 2.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 4.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 3.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 2.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 2.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.1 | 6.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 14.6 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 3.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 5.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 8.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.7 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 2.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.5 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 2.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 31.3 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 3.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 2.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 9.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 4.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 6.8 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 3.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 1.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 3.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.7 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 1.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.6 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 1.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 2.7 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 1.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 2.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 5.7 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.2 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 7.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 1.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.4 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 13.8 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 3.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 93.9 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 2.2 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 4.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 3.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 6.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 22.7 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 8.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 1.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.6 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 1.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 2.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 8.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.3 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 2.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.3 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.4 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 3.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.9 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 2.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.9 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 5.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 5.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 3.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 6.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 12.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 5.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 5.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 4.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 5.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 6.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 6.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 4.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 5.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 3.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 4.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 4.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 6.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 2.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 6.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 6.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 7.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 6.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 2.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 5.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 3.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 6.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 4.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 0.4 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.4 | 3.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 24.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 4.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 2.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 0.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 7.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 6.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 2.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 2.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 2.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 4.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 3.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 3.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 6.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 5.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 3.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.7 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 4.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 4.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 2.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 5.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.5 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 3.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 3.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 1.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 2.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 2.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 2.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 12.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.8 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 4.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 2.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 6.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.9 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 3.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 3.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 18.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 3.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 6.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 3.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 5.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 15.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 7.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |